These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2974094)

  • 1. Hypertension in autosomal dominant polycystic kidney disease.
    Bell PE; Hossack KF; Gabow PA; Durr JA; Johnson AM; Schrier RW
    Kidney Int; 1988 Nov; 34(5):683-90. PubMed ID: 2974094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE; Wilson DM; Burnett JC; Johnson CM; Offord KP
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension in patients with polycystic kidneys--the effect of volume expansion].
    Zabka J; Tesar V; Merta M; Horký K; Petrtýl J; Jedlicka J; Stolba P; Gregorová I; Marecek Z
    Sb Lek; 1991 Oct; 93(9-10):325-38. PubMed ID: 1821466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.
    Barrett BJ; Foley R; Morgan J; Hefferton D; Parfrey P
    Kidney Int; 1994 Oct; 46(4):1118-23. PubMed ID: 7861706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
    Barendregt JN; Florijn KW; Muizert Y; Chang PC
    Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB; Johnson A; Gabow PA; Schrier RW
    N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuresis-pressure relationship in polycystic kidney disease.
    Schmid M; Mann JF; Stein G; Herter M; Nussberger J; Klingbeil A; Ritz E
    J Hypertens; 1990 Mar; 8(3):277-83. PubMed ID: 2159509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal structure and hypertension in autosomal dominant polycystic kidney disease.
    Gabow PA; Chapman AB; Johnson AM; Tangel DJ; Duley IT; Kaehny WD; Manco-Johnson M; Schrier RW
    Kidney Int; 1990 Dec; 38(6):1177-80. PubMed ID: 2074659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic response to volume expansion in polycystic kidney disease.
    Torres VE; Wilson DM; Offord KP; Burnett JC; Romero JC
    Mayo Clin Proc; 1989 May; 64(5):509-15. PubMed ID: 2725063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease.
    Ramunni A; Saracino A; Esposito T; Saliani MT; Coratelli P
    Hypertens Res; 2004 Apr; 27(4):221-5. PubMed ID: 15127878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension of polycystic kidney disease: mechanisms and hemodynamic alterations.
    Valvo E; Gammaro L; Tessitore N; Panzetta G; Lupo A; Loschiavo C; Oldrizzi L; Fabris A; Rugiu C; Ortalda V
    Am J Nephrol; 1985; 5(3):176-81. PubMed ID: 3893129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in polycystic kidney disease without renal failure.
    Nash DA
    Arch Intern Med; 1977 Nov; 137(11):1571-5. PubMed ID: 921444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
    Wang D; Strandgaard S
    J Hypertens; 1997 Sep; 15(9):925-33. PubMed ID: 9321739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates.
    Kaehny WD; Tangel DJ; Johnson AM; Kimberling WJ; Schrier RW; Gabow PA
    Am J Med; 1990 Jul; 89(1):49-52. PubMed ID: 2368793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
    Lawson CR; Doulton TW; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog.
    Zimmerman RS; Schirger JA; Edwards BS; Schwab TR; Heublein DM; Burnett JC
    Circ Res; 1987 Jul; 61(1):63-9. PubMed ID: 2955951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal renal tubular response to changes of sodium intake in hypertensive man.
    Bruun NE; Skøtt P; Damkjaer Nielsen M; Rasmussen S; Schütten HJ; Leth A; Pedersen EB; Giese J
    J Hypertens; 1990 Mar; 8(3):219-27. PubMed ID: 2159502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
    Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
    Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.